market-trends is the sole category represented across all 1 tracked stories. Atea Pharmaceuticals is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 5 original sources on average, compared with 3.2 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about BBOT
market-trends is the sole category represented across all 1 tracked stories. Atea Pharmaceuticals is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 5 original sources on average, compared with 3.2 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 6.8 in the same window. BBOT appears in 1 tracked Startup story from March 5, 2026.
Stories tracked
1
Sources per story
5
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 42 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering BBOT. Shared-story counts are live from our verified record — not editorial picks.
Rumble and a cohort of mid-cap growth companies reported 2025 year-end results, highlighting a shift from pure-play growth to infrastructure-led sustainability. These reports underscore a broader trend of 'platformization' across the technology and biotech sectors as companies seek to insulate themselves from volatile market conditions.
BBOT is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.